首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis
【24h】

Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis

机译:抑制内皮细胞体系(信号肽 - 幼崽-EGF结构域域蛋白2),一种新型VEGFR2(血管内皮生长因子受体2)团簇,抑制肿瘤血管生成

获取原文
获取原文并翻译 | 示例
       

摘要

Objective SCUBE2 (signal peptide-CUB-EGF domain-containing protein 2), expressed on the endothelial cell surface, functions as a novel coreceptor for VEGFR2 (vascular endothelial growth factor receptor 2) and enhances VEGF-induced signaling in adult angiogenesis. However, whether SCUBE2 plays a role in pathological angiogenesis and whether anti-SCUBE2 antibody is an effective strategy for blocking tumor angiogenesis remain unknown. The aim of this study was to investigate the pathological role and targeting therapy of SCUBE2 in tumor vasculature.
机译:目的血液管2(信号肽-Bum-EGF结构域蛋白2)在内皮细胞表面上表达,用作VEGFR2(血管内皮生长因子受体2)的新型团簇,并增强了成年血管生成中的VEGF诱导的信号传导。 然而,Scube2是否在病理血管生成中发挥作用,并且抗鳞状2抗体是阻断肿瘤血管生成的有效策略仍然未知。 本研究的目的是探讨肿瘤脉管系统中苏布欧2的病理作用和靶向治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号